<?xml version="1.0" encoding="UTF-8"?>
<p>NS1 has gained motifs in its CTT which have conferred to NS1 the ability to interact with a wider collection of proteins [
 <xref rid="B107-ijms-21-01511" ref-type="bibr">107</xref>]. There is evidence in the literature that NS1 may interact with the following additional partners: human PAF1 transcription elongation complex (hPAF1C); parafibromin (CDC73), global transcription activator (SNF2L) [
 <xref rid="B108-ijms-21-01511" ref-type="bibr">108</xref>]; chromodomain-helicase-DNA-binding protein 1 (CHD1) [
 <xref rid="B109-ijms-21-01511" ref-type="bibr">109</xref>]; WD repeat-containing protein-5 (WDR5) [
 <xref rid="B109-ijms-21-01511" ref-type="bibr">109</xref>]; β-tubulin [
 <xref rid="B110-ijms-21-01511" ref-type="bibr">110</xref>]; nucleolin, fibrillarin, and nuclear B23 [
 <xref rid="B70-ijms-21-01511" ref-type="bibr">70</xref>]; RNA-associated protein 55 (RAP55) [
 <xref rid="B111-ijms-21-01511" ref-type="bibr">111</xref>]; RNA binding protein nuclear factor 90 (NF90) [
 <xref rid="B112-ijms-21-01511" ref-type="bibr">112</xref>]; heat shock protein 90 (HSP90) [
 <xref rid="B113-ijms-21-01511" ref-type="bibr">113</xref>]; NOD-like receptor family, pyrin domain containing 3 protein (NLRP3) [
 <xref rid="B114-ijms-21-01511" ref-type="bibr">114</xref>]; inhibitor of nuclear factor kappa-B kinase subunits α and β (IKKα and IKKβ) [
 <xref rid="B115-ijms-21-01511" ref-type="bibr">115</xref>]; poly(a)-binding protein II (PABII) [
 <xref rid="B89-ijms-21-01511" ref-type="bibr">89</xref>]; human guanylate-binding protein 1 (hGBP1) [
 <xref rid="B116-ijms-21-01511" ref-type="bibr">116</xref>]; transcription factors p53 and cleavage and polyadenylation specificity factor subunit 4 (CPSF4) [
 <xref rid="B117-ijms-21-01511" ref-type="bibr">117</xref>]; PDZ and LIM domain protein 2 (PDlim2) [
 <xref rid="B118-ijms-21-01511" ref-type="bibr">118</xref>]; membrane-associated guanylate kinase inverted 1, 2 and 3 (MAGI-1,2 and 3, respectively), scribble and discs large homolog 1 (Dlg-1) [
 <xref rid="B119-ijms-21-01511" ref-type="bibr">119</xref>,
 <xref rid="B120-ijms-21-01511" ref-type="bibr">120</xref>]; tyrosine-protein kinase Src (c-Src), tyrosine-protein phosphatase non-receptor type 1 (PTPL1) and reversion-induced LIM protein (RIL) [
 <xref rid="B121-ijms-21-01511" ref-type="bibr">121</xref>]; and adapter molecule crk (CrkI and CrkII) [
 <xref rid="B107-ijms-21-01511" ref-type="bibr">107</xref>].
</p>
